knowledge -WSS

knowledge

author：comprehensive 2025-09-29 19:14:36 - browse：35

ASH19 CAR-T — Victor Segura Ibarra and Rita Serda, Ph.D., NCI, NIH

The Food and Drug Administration on Wednesday approved a futuristic new approach to treating cancer, clearing a Novartis therapy that has produced unprecedented results in patients with a rare and deadly cancer. The price tag: $475,000 for a course of treatment.

That sounds staggering to many patients — but it’s far less than analysts expected.

The therapy, called a CAR-T, is made by harvesting patients’ white blood cells and rewiring them to home in on tumors. Novartis’s product is the first CAR-T therapy to come before the FDA, leading a pack of novel treatments that promise to change the standard of care for certain aggressive blood cancers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Be careful with at

WSS

Idaho college killings prosecutors challenge defense's grand jury claims

Bird flu researchers hone in on Finland’s mink farms

Mass General totes up its waste in a move to tackle climate change

Ending racial health disparities hinges on penalties, political will

Illinois Supreme Court finds assault weapons ban constitutional

Stanford president's case begs question: Who takes blame?

hotspot

knowledge

hotspot

Jerome Adams on the need for new antivirals for Covid

Treatments for cramps don't cut it. Why aren't there better options?

Peter Hotez and the public health issue of online harassment

Judge rejects Trump's request to move Stormy Daniels hush

Walensky prepares to leave CDC — and Congress — behind

Health AI: on the border between health care and tech

The high cost of giving birth even with insurance

Biden administration begins canceling student loan debt for 804,000 borrowers

As demand for Covid shots wanes, Moderna seeks its next success

Awakening the world to the whoosh: A patient's crusade

hotspot

Awakening the world to the whoosh: A patient's crusade

Novo Nordisk touts Wegovy study, but still struggling with supply

Mark Cuban is blaming the wrong people for high drug costs

Why Congress must ban federal programs from using QALYs

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

Stanford president faces new allegations over 1999 paper

leisure time

knowledge

hotspot

Wikipedia